Our Recommendations
- Outcomes of lenacapavir administration during pregnancy (2025)
- Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness (2025)
- Should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP? (2025)
- Systematic review of values and preferences for lenacapavir as pre-exposure prophylaxis and other forms of long-acting injectable PrEP (2025)
- Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review (2025)
New Publications
- Outcomes of lenacapavir administration during pregnancy (2025)
- Lenacapavir-associated drug resistance: implications for scaling up long-acting PrEP (2025)
- Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness (2025)
- Should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP? (2025)
- Systematic review of values and preferences for lenacapavir as pre-exposure prophylaxis and other forms of long-acting injectable PrEP (2025)
Filter
42
Featured
Recommendations
9
New Publications
7
Language
Document type
Guidelines
30
Studies & Reports
6
Fact sheets
4
Infographics
1
No document type
1
Countries / Regions
East and Southern Africa
1
South Africa
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
2
Countries
1
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
Providing expert scientific advice on HIV
EAGA Secretariat
